Found: 3
Select item for more details and to access through your institution.
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1503, doi. 10.1111/jgh.16208
- By:
- Publication type:
- Article
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 1, p. 105, doi. 10.1111/jgh.15107
- By:
- Publication type:
- Article
The Impact of Prolonged pH Measurements on the Diagnosis of Gastroesophageal Reflux Disease: 4-Day Wireless pH Studies.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2007, v. 102, n. 12, p. 2642, doi. 10.1111/j.1572-0241.2007.01461.x
- By:
- Publication type:
- Article